Kenta Teruya
Kenta Teruya
Tohoku University Graduate School of Medicine
Verified email at
Cited by
Cited by
Improved segmental isotope labeling of proteins and application to a larger protein
T Otomo, K Teruya, K Uegaki, T Yamazaki, Y Kyogoku
Journal of biomolecular NMR 14 (2), 105, 1999
Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner
Y Kawasaki, K Kawagoe, C Chen, K Teruya, Y Sakasegawa, K Doh-Ura
Journal of virology 81 (23), 12889-12898, 2007
Identification by NMR spectroscopy of residues at contact surfaces in large, slowly exchanging macromolecular complexes
H Matsuo, KJ Walters, K Teruya, T Tanaka, GT Gassner, SJ Lippard, ...
Journal of the American Chemical Society 121 (42), 9903-9904, 1999
Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors
K Akaji, H Konno, H Mitsui, K Teruya, Y Shimamoto, Y Hattori, T Ozaki, ...
Journal of medicinal chemistry 54 (23), 7962-7973, 2011
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Y Shimamoto, Y Hattori, K Kobayashi, K Teruya, A Sanjoh, A Nakagawa, ...
Bioorganic & medicinal chemistry 23 (4), 876-890, 2015
The influence of PRNP polymorphisms on human prion disease susceptibility: an update
A Kobayashi, K Teruya, Y Matsuura, T Shirai, Y Nakamura, M Yamada, ...
Acta neuropathologica 130, 159-170, 2015
Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection
M Hizume, A Kobayashi, K Teruya, H Ohashi, JW Ironside, S Mohri, ...
Journal of Biological Chemistry 284 (6), 3603-3609, 2009
Synthesis of cyclic RGD derivatives via solid phase macrocyclization using the Heck reaction
K Akaji, K Teruya, M Akaji, S Aimoto
Tetrahedron 57 (12), 2293-2303, 2001
Antiprion activity of functionalized 9-aminoacridines related to quinacrine
HTN Thi, CY Lee, K Teruya, WY Ong, K Doh-ura, ML Go
Bioorganic & medicinal chemistry 16 (14), 6737-6746, 2008
Insights from therapeutic studies for PrP prion disease
K Teruya, K Doh-Ura
Cold Spring Harbor perspectives in medicine 7 (3), a024430, 2017
Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere
K Akaji, K Teruya, S Aimoto
The Journal of Organic Chemistry 68 (12), 4755-4763, 2003
Evaluating prion models based on comprehensive mutation data of mouse PrP
T Shirai, M Saito, A Kobayashi, M Asano, M Hizume, S Ikeda, K Teruya, ...
Structure 22 (4), 560-571, 2014
Heterozygous inhibition in prion infection: the stone fence model
A Kobayashi, M Hizume, K Teruya, S Mohri, T Kitamoto
Prion 3 (1), 27-30, 2009
Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
H Konno, T Onuma, I Nitanai, M Wakabayashi, S Yano, K Teruya, K Akaji
Bioorganic & Medicinal Chemistry Letters 27 (12), 2746-2751, 2017
Polypeptide synthesis using an expressed peptide as a building block for condensation with a peptide thioester: application to the synthesis of phosphorylated p21Max protein (1 …
T Kawakami, K Hasegawa, K Teruya, K Akaji, M Horiuchi, F Inagaki, ...
Journal of Peptide Science: An Official Publication of the European Peptide …, 2001
Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors
M Unno, M Shinohara, K Takayama, H Tanaka, K Teruya, K Doh-Ura, ...
Journal of molecular biology 413 (3), 667-683, 2011
A single subcutaneous injection of cellulose ethers administered long before infection confers sustained protection against prion diseases in rodents
K Teruya, A Oguma, K Nishizawa, M Kawata, Y Sakasegawa, ...
PLoS Pathogens 12 (12), e1006045, 2016
Total synthesis of [L40I, C90A, C109A]-human T-cell leukemia virus type 1 protease
K Teruya, T Kawakami, K Akaji, S Aimoto
Tetrahedron letters 43 (8), 1487-1490, 2002
Amyloidophilic compounds for prion diseases
K Teruya, K Kawagoe, T Kimura, C Chen, Y Sakasegawa, K Doh-ura
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2009
Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells
K Teruya, K Nishizawa, K Doh-Ura
The Protein Journal 29, 493-500, 2010
The system can't perform the operation now. Try again later.
Articles 1–20